CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 67 filers reported holding CULLINAN ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,690 | +5.2% | 250,000 | 0.0% | 0.08% | -45.4% |
| Q1 2023 | $2,558 | -3.0% | 250,000 | 0.0% | 0.15% | +3.4% |
| Q4 2022 | $2,638 | -99.9% | 250,000 | 0.0% | 0.15% | +7.3% |
| Q3 2022 | $3,205,000 | 0.0% | 250,000 | 0.0% | 0.14% | -19.9% |
| Q2 2022 | $3,205,000 | +22.4% | 250,000 | 0.0% | 0.17% | +55.5% |
| Q1 2022 | $2,618,000 | -32.1% | 250,000 | 0.0% | 0.11% | +4.8% |
| Q4 2021 | $3,858,000 | +70.9% | 250,000 | +150.0% | 0.10% | +110.0% |
| Q3 2021 | $2,257,000 | -12.3% | 100,000 | 0.0% | 0.05% | -3.8% |
| Q2 2021 | $2,575,000 | -38.2% | 100,000 | 0.0% | 0.05% | -29.7% |
| Q1 2021 | $4,167,000 | – | 100,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
| CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
| Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
| Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
| Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
| BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
| Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
| Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
| Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
| Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |